A Phase 2, Randomized, Double-blinded, Placebo-controlled, Multicenter, Dose-finding Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects with Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Project: Research

Project Details

StatusFinished
Effective start/end date19/12/19 → 31/12/24

Keywords

  • Non-alcoholic steatohepatitis
  • Liver fibrosis
  • Clinical trial

Clinical Trial Phase

  • Phase II